<DOC>
	<DOCNO>NCT00101335</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention use certain drug keep cancer forming , grow , come back . The use celecoxib may prevent treat head neck cancer . PURPOSE : This randomized phase II trial study celecoxib see well work compare placebo prevent head neck cancer patient oral leukoplakia .</brief_summary>
	<brief_title>Celecoxib Preventing Head Neck Cancer Patients With Oral Leukoplakia</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare clinical efficacy celecoxib v placebo , term induce regression oral leukoplakia lesion , patient hyperplastic dysplastic oral leukoplakia . Secondary - Determine effect drug modulate multiple intermediate biomarkers ( e.g. , COX-2 , PPARγ , PPARδ ) normal hyperplastic dysplastic oral epithelium patient . - Determine safety drug patient . - Determine cost-effectiveness drug chemopreventative agent patient . OUTLINE : This randomize , double-blind , placebo-controlled , cross-over study . Patients stratify accord pathology leukoplakia lesion ( dysplasia v hyperplasia ) . Patients randomize 1 2 arm . - Arm I : Patients receive oral celecoxib twice daily 3 month . - Arm II : Patients receive oral placebo twice daily 3 month . All patient undergo biopsy . Patients cross-over opposite treatment arm 3 month . In arm , treatment continue absence unacceptable toxicity disease progression . Patients follow 1 month . PROJECTED ACCRUAL : A total 27-60 patient ( 18-40 study drug , 9-20 placebo cross-over ) accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Leukoplakia , Oral</mesh_term>
	<mesh_term>Leukoplakia</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis oral leukoplakia hyperplasia dysplasia Documented baseline biopsy oral lesion suspicious leukoplakia For patient use denture past 6 month , lesion locate ventrallateral tongue floor mouth allow No leukoplakia/hyperplasia secondary mechanical irritation No carcinoma situ oral cavity PATIENT CHARACTERISTICS : Age 18 Performance status Not specify Life expectancy At least 1 year Hematopoietic Hemoglobin ≥ 10 g/dL ( woman ) OR ≥ 11 g/dL ( men ) Hepatic AST ALT normal Bilirubin normal Renal Creatinine normal OR Creatinine clearance ≥ 60 mL/min Cardiovascular No myocardial infarction within past 12 month No know active ischemic cardiac disease stress test echocardiogram Gastrointestinal No history gastrointestinal hemorrhage No known gastrointestinal ulcer within past 2 year unless documentation heal lesion upper endoscopy No active suspect peptic ulcer disease Negative stool guaiac test Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 2 month study treatment No use snuff chew tobacco within past 2 month No active invasive malignancy within past 3 year except nonmelanoma skin cancer situ carcinomas No clinical evidence chronic infectious disease No clinical evidence connective tissue disease No know hypersensitivity ( asthma , urticaria , acute rhinitis induce NSAIDs ) aspirin NSAIDs No known hypersensitivity sulfonamide PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy At least 6 month since prior chronic frequent use systemic glucocorticoid No concurrent chronic frequent use systemic glucocorticoid Radiotherapy Not specify Surgery Not specify Other No prior chronic frequent ( &gt; 100 mg per day aspirin equivalent ) use nonsteroidal antiinflammatory drug ( NSAIDs ) 7 past 14 day At least 3 month since prior experimental therapy No concurrent chronic frequent use NSAIDs Cardioprotective dose aspirin ≤ 100 mg daily allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>hypopharyngeal cancer</keyword>
	<keyword>lip oral cavity cancer</keyword>
	<keyword>nasopharyngeal cancer</keyword>
	<keyword>oropharyngeal cancer</keyword>
	<keyword>tongue cancer</keyword>
	<keyword>oral leukoplakia</keyword>
</DOC>